1 min read
Add as a preferred source on GoogleBioAge Labs Posts $0.73 Q3 GAAP Loss Per Share as Revenue Drops 85.7%
Revenue was $0.3 million, missing estimates by $1.18 million. Cash, cash equivalents and marketable securities totaled about $352.3 million at Sept. 30.
BioAge Labs posted a $0.73-per-share GAAP loss for the third quarter, missing estimates as revenue fell 85.7% year over year and its quarter-end cash, equivalents and marketable securities totaled about $352.3 million.
Revenue was $0.3 million, $1.18 million below estimates. The per-share loss exceeded estimates by $0.09.
The company had approximately $352.3 million in cash, cash equivalents and marketable securities as of Sept. 30, 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.